logo
Select company
Select metric
$ -9.03MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
69
Sector
88
Industry
97
History
96
$ 1.14Close
$ 0.3 - $ 10.24 52-Week Range
Ticker Information

Ticker

APLT

Company Name

APPLIED THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

APPLIED THERAPEUTICS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

APLT - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ -9.03M
3/31/2025$ -10.72M
12/31/2024$ 105.09M
9/30/2024$ 144.03M
6/30/2024$ 150.81M
3/31/2024$ 180.41M
12/31/2023$ 64.6M
9/30/2023$ 34.69M
6/30/2023$ 27.87M
3/31/2023$ 27.86M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • APPLIED THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 154.28M.
  • Over the past 5 years, APPLIED THERAPEUTICS INC's average CF - Equity has been $ 69.57M.
  • The median CF - Equity for APPLIED THERAPEUTICS INC during this period was $ 69.77M
  • APPLIED THERAPEUTICS INC reached its highest CF - Equity over the past 5 years at $ 180.41M.
  • The lowest CF - Equity recorded by APPLIED THERAPEUTICS INC in the same timeframe $ -10.72M

APPLIED THERAPEUTICS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
MNOV : MEDICINOVA INC $ 0SER : SERINA THERAPEUTICS INC $ 10.55MENTX : ENTERA BIO LTD $ 16.35MSABS : SAB BIOTHERAPEUTICS INC $ -3INO : INOVIO PHARMACEUTICALS INC $ 30.91MINMB : INMUNE BIO INC $ 40.26MAIM : AIM IMMUNOTECH INC $ 2.06MIMA : IMAGENEBIO INC $ 0HYPD : HYPERION DEFI INC $ 29.66MCNTX : CONTEXT THERAPEUTICS INC $ 14.48M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

APLT - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -10.72M

Minimum

Mar 31, 2025

$ 180.41M

Maximum

Mar 31, 2024

$ 69.57M

Average

$ 69.77M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 94.74K with a standard deviation of $ 17.64M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 94.74K
median$ 0
std$ 17.64M